The effect of intensified low density lipoprotein cholesterol reduction on recurrent myocardial infarction and cardiovascular mortality

Acta Cardiologica Sinica

Volumn 29, Issue 5, 2013, Pages 404-412

  Huang, Wei Chun ^a,b,c   Lin, Tzu Wen ^d   Chiou, Kuan Rau ^a,b   Cheng, Chin Chang ^a,b   Kuo, Feng Yu ^a   Chiang, Cheng Hung ^a   Yang, Jin Shiou ^c   Lin, Ko Long ^d   Hsiao, Shin Hung ^a,b   Yeh, Tong Chen ^a   Mar, Guang Yuan ^a   Hsiao, Hsiang Chiang ^a,b   Lin, Shoa Lin ^a,b   Chiou, Chuen Wang ^a,b   Liu, Chun Peng ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d CHENG SHIU UNIVERSITY   (Taiwan)

Author keywords

Acute myocardial infarction; Cardiovascular death; Low density lipoprotein cholesterol; Mortality; Statin

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPLETE HEART BLOCK; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; RECURRENT DISEASE; RESUSCITATION; SURVIVAL RATE;

EID: 84886936557     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wong CP, Loh SY, Loh KK, et al. Acute myocardial infarction: clinical features and outcomes in young adults in Singapore. World J Cardiol 2012;4:206-10.
2. Shyu KG, Wu CJ, Mar GY, et al. Clinical characteristics, management and in-hospital outcomes of patients with acute coronary syndrome - observations from the Taiwan ACS full spectrum registry. Acta Cardiol Sin 2011;27:135-44.
3. Li YH, Yeh HI, Tsai CT, et al. 2012 guidelines of the Taiwan Society of Cardiology (TSOC) for the management of ST-segment elevation myocardial infarction. Acta Cardiol Sin 2012;28:63-89.
4. Huang WC, Chiou KR, Liu CP, et al. Multidetector row computed tomography can identify and characterize the occlusive culprit lesions in patients early (within 24 hours) after acutemyocardial infarction. Am Heart J 2007;154:914-22.
5. Liu CP, Lin YH, Lin MS, et al. Evaluation ofmyocardial infarction patients after coronary revasculation by dual-phase multi-detector computed tomography: now and in future.World J Cardiol 2013;5:115-8.
6. Hsu HP, Jou YL, Lin SJ, et al. Comparison of in-hospital outcome of acute ST elevation myocardial infarction in patients with versus without diabetes mellitus. Acta Cardiol Sin 2011:145-51.
7. Hsu HP, Jou YL,Wu TC, et al. Hyperglycemia increases new-onset atrial fibrillation in patients with acute ST-elevation myocardial infarction. Acta Cardiol Sin 2012;28:279-85.
8. Huang SS, Leu HB, Lu TM, et al. The impacts of in-hospital invasive strategy on long-term outcome in elderly patients with non-ST-elevation myocardial infarction. Acta Cardiol Sin 2013; 29:115-23.
9. Wang WH, Hsiao SH, Chiou KR, et al. Limited efficacy of myocardial tissue doppler for predicting left ventricular filling pressure, severe pulmonary edema, and respiratory failure in acute myocardial infarction. Acta Cardiol Sin 2012;28:206-15.
10. Huang WC, Liu CP, Wu MT, et al. Comparing culprit lesions in ST-segment elevation and non-ST-segment elevation acute coronary syndrome with 64-slice multidetector computed tomography. Eur J Radiol 2010;73:74-81.
11. HuangWC,Wu MT, Chiou KR, et al. Assessing culprit lesions and active complex lesions in patients with early acute myocardial infarction by multidetector computed tomography. Circ J 2008; 72:1806-13.
12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
13. Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med 1999;340:115-26.
14. Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976;193:1094-100.
15. Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007;49: 1272-8.
16. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New Engl JMed 2004;350:1495-504.
17. Stenestrand U,Wallentin L, Swedish Register of Cardiac Intensive C. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-6.
18. Fonarow GC, Wright RS, Spencer FA, et al. Effect of statin use within the first 24 hours of admission for acutemyocardial infarction on early morbidity and mortality. Am J Cardiol 2005;96: 611-6.
19. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-8.
20. Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 2001;357:1063-8.
21. Llevadot J, Giugliano RP, Antman EM, et al. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J 2001;22:2104-15.
22. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227- 39.
23. Nishiwaki T, Kishi D, Yoshie F, et al. Relationship between LDL-C reduction after coronary revascularization and prevention of recurrence of cardiovascular events. J Pharm Pharm Sci 2010; 13:254-62.
24. O'Keefe JH Jr, Cordain L, Harris WH, et al. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142-6.
25. Thompson PL. Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients. Atheroscler Suppl 2001;2:15-9.
26. Thompson PL, Meredith I, Amerena J, et al. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J 2004; 148:e2.
27. European Association for Cardiovascular P, Rehabilitation, Reiner Z, et al. ESC/EAS Guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32: 1769-818.
28. Natsuaki M, Furukawa Y, Morimoto T, et al. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2. Circ J 2012;76:1369-79.
29. Sakamoto T,Ogawa H. "Just make it lower" is an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL-cholesterol: The lower, the better; is it true for Asians? (Con). Circ J 2010;74:1731-41.
30. Lee JH, Park SH, Yang DH, et al. Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction. Clin Cardiol 2012;35:211-8.